These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37644431)

  • 1. A co-formulation of interferons alpha2b and gamma distinctively targets cell cycle in the glioblastoma-derived cell line U-87MG.
    Miranda J; Vázquez-Blomquist D; Bringas R; Fernandez-de-Cossio J; Palenzuela D; Novoa LI; Bello-Rivero I
    BMC Cancer; 2023 Aug; 23(1):806. PubMed ID: 37644431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomics and Phospho-Proteomics Profiling of the Co-Formulation of Type I and II Interferons, HeberFERON, in the Glioblastoma-Derived Cell Line U-87 MG.
    Vázquez-Blomquist D; Hardy-Sosa A; Baez SC; Besada V; Palomares S; Guirola O; Ramos Y; Wiśniewski JR; González LJ; Bello-Rivero I
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552831
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A co-formulation of interferons type I and II enhances temozolomide response in glioblastoma with unmethylated MGMT promoter status.
    Vázquez-Blomquist D; Leenstra S; van der Kaaij M; Villarreal A; Bello-Rivero I
    Mol Biol Rep; 2020 Jul; 47(7):5263-5271. PubMed ID: 32607953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HeberFERON, a new formulation of IFNs with improved pharmacodynamics: Perspective for cancer treatment.
    Bello-Rivero I; Garcia-Vega Y; Duncan-Roberts Y; Vazquez-Blomquistc D; Santana-Milian H; Besada-Perez V; Rios-Cabrera M
    Semin Oncol; 2018 Jan; 45(1-2):27-33. PubMed ID: 30318081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of major histocompatibility complex Class I molecules and major histocompatibility complex-bound immunogenic peptides induced by interferon-alpha and interferon-gamma treatment of human glioblastoma multiforme.
    Yang I; Kremen TJ; Giovannone AJ; Paik E; Odesa SK; Prins RM; Liau LM
    J Neurosurg; 2004 Feb; 100(2):310-9. PubMed ID: 15086239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of deletion-mutant epidermal growth factor receptor is associated with altered genotoxic stress-provoked p53 mRNA induction in a human glioblastoma cell line.
    Halatsch ME; Schmidt U; Bötefür IC; Holland JF; Ohnuma T
    Anticancer Res; 2001; 21(1A):189-95. PubMed ID: 11299733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell Cycle Arrest in G
    Bressy C; Droby GN; Maldonado BD; Steuerwald N; Grdzelishvili VZ
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30487274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tetra-O-methyl nordihydroguaiaretic acid, an inhibitor of Sp1-mediated survivin transcription, induces apoptosis and acts synergistically with chemo-radiotherapy in glioblastoma cells.
    Castro-Gamero AM; Borges KS; Moreno DA; Suazo VK; Fujinami MM; de Paula Gomes Queiroz R; de Oliveira HF; Carlotti CG; Scrideli CA; Tone LG
    Invest New Drugs; 2013 Aug; 31(4):858-70. PubMed ID: 23299390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Derivatives of Tetrahydrobenzo (g) Imidazo[α-1,2] Quinoline Induce Apoptosis Via ROS Production in the Glioblastoma Multiforme Cells, U-87MG.
    Mostafavi Hosseini F; Ashourpour M; Taheri S; Tavakoli Yaraki M; Salami S; Shahsavari Z; Kazerouni F
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3885-3893. PubMed ID: 36444602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT6 expression in glioblastoma promotes invasive growth.
    Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
    BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase.
    Li W; Liu J; Fu W; Zheng X; Ren L; Liu S; Wang J; Ji T; Du G
    J Exp Clin Cancer Res; 2018 Jul; 37(1):132. PubMed ID: 29970196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation by IFN-α/IFN-γ co-formulation (HerberPAG®) of genes involved in interferon-STAT-pathways and apoptosis in U87MG.
    Bello C; Vazquez-Blomquist D; Miranda J; Garcia Y; Novoa LI; Palenzuela D; Bello I
    Curr Top Med Chem; 2014; 14(3):351-8. PubMed ID: 24304312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Andrographolide Induces G2/M Cell Cycle Arrest and Apoptosis in Human Glioblastoma DBTRG-05MG Cell Line via ERK1/2 /c-Myc/p53 Signaling Pathway.
    Othman NS; Mohd Azman DK
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hairless regulates p53 target genes to exert tumor suppressive functions in glioblastoma.
    Brook L; Palade P; Maatough A; Whitfield GK; Emeterio LS; Hsieh D; Hsieh JC
    J Cell Biochem; 2019 Jan; 120(1):533-543. PubMed ID: 30191601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Oxoeudesm-11(13)-eno-12,8a-lactone induces G2/M arrest and apoptosis of human glioblastoma cells in vitro.
    Liu SS; Wang YF; Ma LS; Zheng BB; Li L; Xie WD; Li X
    Acta Pharmacol Sin; 2013 Feb; 34(2):271-81. PubMed ID: 23160341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro anti-synovial sarcoma effect of diallyl trisulfide and mRNA profiling.
    Xia SL; Ma ZY; Wang B; Gao F; Yi CG; Zhou XX; Guo SY; Zhou L
    Gene; 2022 Mar; 816():146172. PubMed ID: 34995734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polo-like kinase 1 inhibition causes decreased proliferation by cell cycle arrest, leading to cell death in glioblastoma.
    Pezuk JA; Brassesco MS; Morales AG; de Oliveira JC; de Paula Queiroz RG; Machado HR; Carlotti CG; Neder L; Scrideli CA; Tone LG
    Cancer Gene Ther; 2013 Sep; 20(9):499-506. PubMed ID: 23887645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of gene expression profile in rat Kupffer cells stimulated with IFN-alpha or IFN-gamma.
    Zocco MA; Carloni E; Pescatori M; Saulnier N; Lupascu A; Nista EC; Novi M; Candelli M; Cimica V; Mihm S; Gasbarrini G; Ramadori G; Gasbarrini A
    Dig Liver Dis; 2006 Aug; 38(8):563-77. PubMed ID: 16807150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression time-series analysis of camptothecin effects in U87-MG and DBTRG-05 glioblastoma cell lines.
    Morandi E; Severini C; Quercioli D; D'Ario G; Perdichizzi S; Capri M; Farruggia G; Mascolo MG; Horn W; Vaccari M; Serra R; Colacci A; Silingardi P
    Mol Cancer; 2008 Aug; 7():66. PubMed ID: 18694480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic therapeutic benefit by combining the antibody drug conjugate, depatux-m with temozolomide in pre-clinical models of glioblastoma with overexpression of EGFR.
    Vaidya KS; Mitten MJ; Zelaya-Lazo AL; Oleksijew A; Alvey C; Falls HD; Mishra S; Palma J; Ansell P; Phillips AC; Reilly EB; Anderson M; Boghaert ER
    J Neurooncol; 2021 Apr; 152(2):233-243. PubMed ID: 33517558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.